Follow us on




Q of the week

Q: How Do You Get Shingles?

Get the Answer: 

Prototype devices

It is recognized that a manufacturer may wish to submit a small number  of "prototype models" of a device to clinical investigation in order to assess safety and/or performance; and those such prototypes may need to undergo a number of changes prior to large-scale production.

 Forums
Welcome Guest   [Register]  [Login]
EFGCP–EUCROF Joint Workshop Final Report   by  on 2010-08-20 20:12:20
Managing Clinical Trials   by  on 2010-07-16 00:05:32
US-FDA issues Revised Info Sheet Guidance on Clinical Investigator Disqualification   by  on 2010-06-13 18:11:41
US-FDA issues final guidance on Statement of Investigator (Form FDA 1572)   by  on 2010-06-13 18:07:59
Rising Clinical Trial Complexity Continues to Vex Drug Developers   by  on 2010-06-03 17:36:33
Investigator-Driven Clinical Trials: An ESF Forward Look   by  on 2010-06-03 17:27:58
NIH's Financial Conflict of Interest (FCOI) Proposed Rule   by  on 2010-05-27 19:42:00
AAP’s Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Population   by  on 2010-05-13 19:39:54
Argentina: ANMAT - new regulatory update   by  on 2010-05-01 09:40:32
The Wall Street Journal's special supplement on clinical trials   by  on 2010-05-01 09:31:52
Major developments in EU Clinical Trial Guidances   by  on 2010-04-21 03:10:55
Analysis of the adverse reactions induced by natural product-derived drugs   by  on 2010-04-19 07:16:06
Newer Antibacterial Drugs for a New Century   by  on 2010-04-19 06:49:47
Newer Non-Statin Drugs for Reducing Cholesterol   by  on 2010-04-13 15:57:20
Practice Guidelines for Chronic Pain Management   by  on 2010-04-05 04:52:16
CONSORT III (2010)   by  on 2010-03-29 20:53:28
US FDA Draft Guidance on Pharmacokinetics in Patients with Impaired Renal Function   by  on 2010-03-20 20:25:16
US-FDA issues First Draft Guidance on Noninferiority Trials   by  on 2010-03-04 22:07:46
US FDA new rule on reporting information regarding falsification of data   by  on 2010-02-26 04:47:33
US-FDA Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials   by  on 2010-02-06 20:12:14
 Subject :Siddha research centre claims Siddha medicine can prevent & cure H.. 2009-08-18 18:10:52 
M.Anusha
Newbie
Joined: 2009-07-29 10:23:16
Posts: 9
Location
Subject :Siddha research centre claims Siddha medicine can prevent & cure H1N1 influenza

The Chennai-based Centre for Traditional Medicine and Research (CTMR), an institute that conducts research in Siddha medicine and giving training to physicians of Siddha, claims to have discovered a new therapy with some Siddha medicinal plants and formulations that can prevent and cure the pandemic H1N1 viruses without any side effects.

The CTMR has written to the Department of Ayush (Union Health Ministry) in this regard with a request to evaluate the effect of Siddha medicinal plants and formulations for anti-viral activity against stains of H1N1 virus, which is currently spreading throughout the country and taking lives across the world.

The institute has made an attempt to draw the attention of the Ayush top brass to the clinical experiences of Siddha doctors in the state on the effect of Nilavembu Kudineer (a Siddha formulation), in viral diseases including certain pandemic fever. It also explained the 'Neuraminidase inhibitor activity' of Andrographis paniculata (Nilavembu) in studies carried out elsewhere (China). The bicyclic diterpenoids present in the plant has a significant activity. This Neuraminidase inhibition activity prevents H1N1 virus multiplication, said the Secretary of the Centre.

In the letter addressed to the Secretary of Ayush, the secretary of the Centre Dr V Thirunarayanan said the potential of medicinal plants which are well known for their antiviral activity was proven in the National Institute of Virology, Pune under ICMR and some other competent institutes like Haffkins Institute, Mumbai. He requested the authorities to initiate immediate measures in this regard and consider it as an additional and important effort from the Ayush's side towards combating the epidemic. The Influenza caused by A H1N1 (Swine Flu) is attaining epidemic proportion in different states including Tamil Nadu, Karnataka, Kerala and Maharashtra. The centre also praised the governments at the central and state levels for various measures being taken to contain the disease spread.

He further wanted the Department of Ayush to initiate in-vitro and in-vivo researches on this plant drugs and Siddha formulations at National Institute of Virology, Pune, so that scientific data can be generated which will finally help millions of sufferers of virus diseases.

Meanwhile, doctors of Ayurveda have also made claims that their system contains medications for treating H1N1 disease. An ayurvedic doctor from Salem said the disease, its symptoms and its treatment have been mentioned in the ayurvedic medical texts.
IP Logged
Page # 


Powered by ccBoard